Hematopoietic Stem Cell Transplant for Aplastic Anemia Is Feasible in a Tier-2 City: An Experience from an Eastern State of India.

Key Points

• Hematopoietic stem cell transplant offers viable treatment for aplastic anemia, enhancing patient outcomes.
• Data from a tier-2 city support the option for patients needing medical intervention.
• The analysis included various patient demographics, addressing a significant healthcare gap in India.
• These findings indicate that specialized treatments can be effectively conducted outside of major urban centers.